Analyst warns Inspire Medical has a problem lasting into 2028
Inspire Medical has spent years building a compelling sleep apnea device story, but Bank of America says the stock now faces a reimbursement problem that could take longer to resolve than investors want to hear. BofA Securities downgraded Inspire Medical (INSP) to Underperform from Neutral and …
Inspire Medical has spent years building a compelling sleep apnea device story, but Bank of America says the stock now faces a reimbursement problem that could take longer to resolve than investors want to hear. BofA Securities downgraded Inspire Medical (INSP) to Underperform from Neutral and …
Inspire Medical has spent years building a compelling sleep apnea device story, but Bank of America says the stock now faces a reimbursement problem that could take longer to resolve than investors want to hear. BofA Securities downgraded Inspire Medical (INSP) to Underperform from Neutral and …
The full story continues on The Street.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.